Selective and potent inhibitory antibodies of myostatin activation
US12338279B2 · kind B2 · utility
0Cited by
30References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2024 |
| Grant date | Jun 24, 2025 |
| Priority date | — |
| Expiry date | Dec 19, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to antibodies and antigen-binding fragments that specifically bind to pro/latent myostatin and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.